deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT02042326

Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations (MAV-RAPA)

Sponsor: Centre Hospitalier Universitaire, Amiens

Conditions Arteriovenous Malformations
Interventions Sirolimus
Updated 11 times since 2017 Last updated: Feb 7, 2023 Started: Sep 12, 2014 Primary completion: Sep 30, 2024 Completion: Sep 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Arteriovenous Malformations, this trial is ongoing. The trial is conducted by Centre Hospitalier Universitaire, Amiens and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Aug 2020 · 23 months · monthly snapshotRecruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotRecruiting~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotRecruiting~Sep 2021 – ~Mar 2023 · 18 months · monthly snapshotRecruiting~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotRecruiting~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Mar 2025 — Sep 2025 [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  3. Sep 2024 — Mar 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Mar 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

▶ Show 6 earlier versions

  1. Sep 2021 — Mar 2023 [monthly]

    Recruiting PHASE2

  2. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  3. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  4. Sep 2018 — Aug 2020 [monthly]

    Recruiting PHASE2

  5. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE2

  6. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire, Amiens
Data source: Centre Hospitalier Universitaire, Amiens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Bordeaux, France , Brussels, Belgium , Dijon, France , Lille, France , Lyon, France , Marseille, France , Montpellier, France , Nancy, France , Nice, France and 3 more locations